Literature DB >> 24324009

SirT3 regulates the mitochondrial unfolded protein response.

Luena Papa1, Doris Germain.   

Abstract

The mitochondria of cancer cells are characterized by elevated oxidative stress caused by reactive oxygen species (ROS). Such an elevation in ROS levels contributes to mitochondrial reprogramming and malignant transformation. However, high levels of ROS can cause irreversible damage to proteins, leading to their misfolding, mitochondrial stress, and ultimately cell death. Therefore, mechanisms to overcome mitochondrial stress are needed. The unfolded protein response (UPR) triggered by accumulation of misfolded proteins in the mitochondria (UPR(mt)) has been reported recently. So far, the UPR(mt) has been reported to involve the activation of CHOP and estrogen receptor alpha (ERα). The current study describes a novel role of the mitochondrial deacetylase SirT3 in the UPR(mt). Our data reveal that SirT3 acts to orchestrate two pathways, the antioxidant machinery and mitophagy. Inhibition of SirT3 in cells undergoing proteotoxic stress severely impairs the mitochondrial network and results in cellular death. These observations suggest that SirT3 acts to sort moderately stressed from irreversibly damaged organelles. Since SirT3 is reported to act as a tumor suppressor during transformation, our findings reveal a dual role of SirT3. This novel role of SirT3 in established tumors represents an essential mechanism of adaptation of cancer cells to proteotoxic and mitochondrial stress.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24324009      PMCID: PMC3911493          DOI: 10.1128/MCB.01337-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin.

Authors:  Michael Lazarou; Seok Min Jin; Lesley A Kane; Richard J Youle
Journal:  Dev Cell       Date:  2012-01-25       Impact factor: 12.270

Review 2.  Quality control of mitochondrial proteostasis.

Authors:  Michael J Baker; Takashi Tatsuta; Thomas Langer
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

3.  Estrogen receptor mediates a distinct mitochondrial unfolded protein response.

Authors:  Luena Papa; Doris Germain
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

Review 4.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

5.  Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.

Authors:  Markus D Siegelin; Takehiko Dohi; Christopher M Raskett; Gregory M Orlowski; Christine M Powers; Candace A Gilbert; Alonzo H Ross; Janet Plescia; Dario C Altieri
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

Review 6.  Mitochondrial sirtuins in the regulation of mitochondrial activity and metabolic adaptation.

Authors:  David B Lombard; Daniel X Tishkoff; Jianjun Bao
Journal:  Handb Exp Pharmacol       Date:  2011

7.  The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives.

Authors:  Steven H Bernstein; Sundararajan Venkatesh; Min Li; Jae Lee; Bin Lu; Shannon P Hilchey; Kimberly M Morse; Hollie M Metcalfe; Jolanta Skalska; Michael Andreeff; Paul S Brookes; Carolyn K Suzuki
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

Review 8.  Cancer cell metabolism: one hallmark, many faces.

Authors:  Jason R Cantor; David M Sabatini
Journal:  Cancer Discov       Date:  2012-09-25       Impact factor: 39.397

Review 9.  Physiological roles of mitochondrial reactive oxygen species.

Authors:  Laura A Sena; Navdeep S Chandel
Journal:  Mol Cell       Date:  2012-10-26       Impact factor: 17.970

10.  Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster.

Authors:  I Pimenta de Castro; A C Costa; D Lam; R Tufi; V Fedele; N Moisoi; D Dinsdale; E Deas; S H Y Loh; L M Martins
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

View more
  100 in total

Review 1.  Mitochondria and FOXO3 in stem cell homeostasis, a window into hematopoietic stem cell fate determination.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  J Bioenerg Biomembr       Date:  2017-06-21       Impact factor: 2.945

2.  Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.

Authors:  Zixing Fu; Fang Liu; Chunyue Liu; Beifang Jin; Yueqing Jiang; Mingliang Tang; Xin Qi; Xing Guo
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-23       Impact factor: 5.187

Review 3.  The mitochondrial unfolded protein response: Signaling from the powerhouse.

Authors:  Mohammed A Qureshi; Cole M Haynes; Mark W Pellegrino
Journal:  J Biol Chem       Date:  2017-07-07       Impact factor: 5.157

Review 4.  From discovery of the CHOP axis and targeting ClpP to the identification of additional axes of the UPRmt driven by the estrogen receptor and SIRT3.

Authors:  Timothy C Kenny; Doris Germain
Journal:  J Bioenerg Biomembr       Date:  2017-08-10       Impact factor: 2.945

Review 5.  Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR.

Authors:  Pan Deng; Cole M Haynes
Journal:  Semin Cancer Biol       Date:  2017-05-10       Impact factor: 15.707

6.  The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases.

Authors:  Hyon-Seung Yi; Joon Young Chang; Minho Shong
Journal:  J Mol Endocrinol       Date:  2018-05-30       Impact factor: 5.098

7.  Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock.

Authors:  Deborah M Muoio
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

Review 8.  Mitochondrial proteostasis in the control of aging and longevity.

Authors:  Martin Borch Jensen; Heinrich Jasper
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

Review 9.  Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.

Authors:  Jasmine George; Nihal Ahmad
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

Review 10.  Could Sirtuin Activities Modify ALS Onset and Progression?

Authors:  Bor Luen Tang
Journal:  Cell Mol Neurobiol       Date:  2016-12-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.